10/15/2025

Quarterly OARRS Updates from the Ohio Board of Pharmacy

Don't forget to read the quarterly OARRS Newsletter

Established in 2006, the Ohio Automated Rx Reporting System (OARRS) collects information on all outpatient prescriptions for controlled substances and two non-controlled substances (gabapentin & naltrexone) dispensed by Ohio-licensed pharmacies and personally furnished by Ohio prescribers. If you use OARRS in your practice, don't miss these timely updates from the OARRS quarterly newsletter.

Read the OARRS Fall Quarterly Newsletter from the Ohio Board of Pharmacy

This newsletter includes:

• Updates to the OARRS Patient Reports to include information:
  • On patients who may be experiencing MOUD treatment discontinuation
  • On patients who may meet criteria in the Ohio Administrative Code that require a provider to offer a prescription for an overdose reversal medication 
• Other important system updates, including Prescriber and Dispenser threshold alerts
• The importance of PMPAware Emails
• Overview of OARRS Accounts
• OARRS Data Submission, including: 
  • Data Accuracy
  • Data Reporting Requirements
  • ICD-10 / CDT Codes
• A reminder that the electronic format for transmitting prescription dispensation information to OARRS needs to be compliant with the ASAP 5.0 data standard by July 1, 2026